IRLA · Company research
IRulya Therapeutics Inc. Common Stock (IRLA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
12records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Quince Therapeutics (IRLA) Stock Chart and Price History 2026 $IRLA - MarketBeat | Quince Therapeutics (IRLA) Stock Chart and Price History 2026 $IRLA MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| Quince Therapeutics (IRLA) Stock Price, News & Analysis $IRLA - MarketBeat | Quince Therapeutics (IRLA) Stock Price, News & Analysis $IRLA MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| IRulya Therapeutics Inc.: Performance & Quotes, IRLA Stock Price on Nasdaq Exchange - www.marketscreener.com | IRulya Therapeutics Inc.: Performance & Quotes, IRLA Stock Price on Nasdaq Exchange www.marketscreener.com | View source ↗ | www.marketscreener.com | Oct 14, 2026 | neutral | 0 | 0.6 |
| Quince Therapeutics (IRLA) Stock Forecast and Price Target 2026 $IRLA - MarketBeat | Quince Therapeutics (IRLA) Stock Forecast and Price Target 2026 $IRLA MarketBeat | View source ↗ | MarketBeat | Oct 13, 2026 | neutral | 0 | 0.6 |
| IRulya Therapeutics (Nasdaq:IRLA) - Stock Analysis - Simply Wall Street | IRulya Therapeutics (Nasdaq:IRLA) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 13, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 12, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 12, 2026 | neutral | 0 | 0.6 |
| Average basic shares outstanding of IRulya Therapeutics Inc. – NASDAQ:IRLA - TradingView | Average basic shares outstanding of IRulya Therapeutics Inc. – NASDAQ:IRLA TradingView | View source ↗ | TradingView | Oct 12, 2026 | neutral | 0 | 0.6 |
| IRulya Therapeutics Inc. Stock Grades | IRLA - Barron's | IRulya Therapeutics Inc. Stock Grades | IRLA Barron's | View source ↗ | Barron's | Oct 12, 2026 | neutral | 0 | 0.6 |
| Total common shares outstanding of Quince Therapeutics, Inc. – NASDAQ:IRLA - TradingView | Total common shares outstanding of Quince Therapeutics, Inc. – NASDAQ:IRLA TradingView | View source ↗ | TradingView | Oct 12, 2026 | neutral | 0 | 0.6 |
| Quince Therapeutics, Inc. Statistics – NASDAQ:IRLA - TradingView | Quince Therapeutics, Inc. Statistics – NASDAQ:IRLA TradingView | View source ↗ | TradingView | Oct 12, 2026 | neutral | 0 | 0.6 |
| A $116 million cash balance on June 30, 2026, is expected to fund IRulya's operations through 2028. - Stock Titan | A $116 million cash balance on June 30, 2026, is expected to fund IRulya's operations through 2028. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.